These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16599260)

  • 41. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nicotine carbomer enemas--pharmacokinetics of a revised formulation.
    Green JT; Rhodes J; Thomas GA; Evans BK; Feyerabend C; Russell MA; Sandborn WJ
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):260-5. PubMed ID: 9759592
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transbuccal tablets of carbamazepine: formulation, release and absorption pattern.
    Giannola LI; De Caro V; Giandalia G; Siragusa MG; D'Angelo M; Lo Muzio L; Campisi G
    Int J Immunopathol Pharmacol; 2005; 18(3 Suppl):21-31. PubMed ID: 16848984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro and in vivo evaluation of a novel mucoadhesive buccal oxytocin tablet prepared with Dillenia indica fruit mucilage.
    Metia PK; Bandyopadhyay AK
    Pharmazie; 2008 Apr; 63(4):270-4. PubMed ID: 18468385
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Formulation development of oral controlled release tablets of hydralazine: optimization of drug release and bioadhesive characteristics.
    Singh B; Pahuja S; Kapil R; Ahuja N
    Acta Pharm; 2009 Mar; 59(1):1-13. PubMed ID: 19304554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Buccal absorption of diazepam is improved when administered in bioadhesive tablets-An in vivo study in conscious Göttingen mini-pigs.
    Meng-Lund E; Jacobsen J; Müllertz A; Jørgensen EB; Holm R
    Int J Pharm; 2016 Dec; 515(1-2):125-131. PubMed ID: 27697631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Formulation and characterisation of a buccoadhesive erodible tablet for the treatment of oral lesions.
    Ali J; Khar RK; Ahuja A
    Pharmazie; 1998 May; 53(5):329-34. PubMed ID: 9631501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of exercise and nicotine replacement therapy on smoking rates in women.
    Prapavessis H; Cameron L; Baldi JC; Robinson S; Borrie K; Harper T; Grove JR
    Addict Behav; 2007 Jul; 32(7):1416-32. PubMed ID: 17097814
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discontinuation of nicotine replacement therapy among smoking-cessation attempters.
    Burns EK; Levinson AH
    Am J Prev Med; 2008 Mar; 34(3):212-5. PubMed ID: 18312809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of an anti-cotinine vaccine to potentiate nicotine-based smoking cessation strategies.
    Oliver JL; Pashmi G; Barnett P; Mettens P; Biemans R; Monteyne P; Palmantier R; Gallagher T; Ramaya S; Wonnacott S
    Vaccine; 2007 Oct; 25(42):7354-62. PubMed ID: 17870213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spray-dried Amioca starch/Carbopol 974P mixtures as buccal bioadhesive carriers.
    Ameye D; Mus D; Foreman P; Remon JP
    Int J Pharm; 2005 Sep; 301(1-2):170-80. PubMed ID: 16019172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of transdermal system containing nicotine by using sustained release dosage design.
    Tirnaksiz F; Yuce Z
    Farmaco; 2005 Sep; 60(9):763-70. PubMed ID: 16019001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation.
    Cheng YH; Watts P; Hinchcliffe M; Hotchkiss R; Nankervis R; Faraj NF; Smith A; Davis SS; Illum L
    J Control Release; 2002 Feb; 79(1-3):243-54. PubMed ID: 11853935
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nicotine enemas for treatment of ulcerative colitis: a study of the pharmacokinetics and adverse events associated with three doses of nicotine.
    Ingram JR; Routledge P; Rhodes J; Marshall RW; Buss DC; Evans BK; Feyerabend C; Thomas GA
    Aliment Pharmacol Ther; 2004 Oct; 20(8):859-65. PubMed ID: 15479357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hydrotalcite composites for an effective fluoride buccal administration: a new technological approach.
    Perioli L; Nocchetti M; Giannelli P; Pagano C; Bastianini M
    Int J Pharm; 2013 Sep; 454(1):259-68. PubMed ID: 23850817
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A randomized trial of notriptyline combined with transdermal nicotine for smoking cessation].
    Rev Port Pneumol; 2005; 11(6):597-9. PubMed ID: 16514720
    [No Abstract]   [Full Text] [Related]  

  • 57. Simultaneous determination of mecamylamine, nicotine, and cotinine in plasma by gas chromatography-mass spectrometry.
    Jacob P; Wu S; Yu L; Benowitz NL
    J Pharm Biomed Anal; 2000 Sep; 23(4):653-61. PubMed ID: 10975241
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro/in vivo correlation of the bioadhesive properties of a buccal bioadhesive miconazole slow-release tablet.
    Bouckaert S; Lefebvre RA; Remon JP
    Pharm Res; 1993 Jun; 10(6):853-6. PubMed ID: 8321853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Replacement therapy with nicotine. Practical aspects].
    Jiménez Ruiz CA
    Rev Clin Esp; 1998 Mar; 198(3):181-5. PubMed ID: 9586445
    [No Abstract]   [Full Text] [Related]  

  • 60. Population pharmacokinetic model of transdermal nicotine delivered from a matrix-type patch.
    Linakis MW; Rower JE; Roberts JK; Miller EI; Wilkins DG; Sherwin CMT
    Br J Clin Pharmacol; 2017 Dec; 83(12):2709-2717. PubMed ID: 28771779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.